FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that it has been invited to present at the SMH Capital (formerly known as Sanders Morris Harris) Investor Growth Conference. The conference is being held on November 8-9, 2007, at the New York Palace Hotel, in New York and will be attended by securities analysts, fund managers and institutional investors.
